Rockwell Medical (RMTI) Projected to Post Earnings on Thursday

Rockwell Medical (NASDAQ:RMTI) will likely be announcing its Q2 2025 earnings results before the market opens on Thursday, August 14th. Analysts expect the company to announce earnings of ($0.05) per share and revenue of $16.33 million for the quarter. Rockwell Medical has set its FY 2025 guidance at EPS.

Rockwell Medical (NASDAQ:RMTI) last issued its quarterly earnings data on Monday, May 12th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.01). Rockwell Medical had a negative net margin of 0.27% and a negative return on equity of 0.90%. The business had revenue of $18.91 million for the quarter, compared to analyst estimates of $17.46 million. On average, analysts expect Rockwell Medical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Rockwell Medical Trading Down 3.4%

RMTI opened at $0.97 on Thursday. Rockwell Medical has a fifty-two week low of $0.78 and a fifty-two week high of $5.15. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.50 and a current ratio of 2.95. The company’s 50-day moving average is $0.98 and its 200 day moving average is $1.28.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised Rockwell Medical from a “sell” rating to a “hold” rating in a research note on Saturday, June 14th.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.